Uncontrolled, Moderate to Severe Asthma: Identifying Eligible Patients for Targeted Biologic Therapy

Ian M. Adcock, PhD, FRSB, FBPhS, FERS, discusses asthma in this CME activity titled "Navigating the Relationship Between Type 2 Inflammation and Uncontrolled, Moderate to Severe Asthma: Identifying Eligible Patients for Targeted Biologic Therapy." For the full presentation, downloadable infographics, and complete CME information, and to apply for credit, please visit us at PeerView.com/KGQ865. CME credit will be available until December 6, 2021